Dynamic treatment regimes using Bayesian additive regression trees for censored outcomes
DOI10.1007/S10985-023-09605-8arXiv2210.13330MaRDI QIDQ6205050FDOQ6205050
Authors:
Publication date: 11 April 2024
Published in: Lifetime Data Analysis (Search for Journal in Brave)
Full work available at URL: https://arxiv.org/abs/2210.13330
survival analysisprecision medicineindividualized treatment rulesaccelerated failure time (AFT)allogeneic hematopoietic cell transplantation
Applications of statistics to biology and medical sciences; meta analysis (62P10) Survival analysis and censored data (62Nxx)
Cites Work
- BART: Bayesian additive regression trees
- Modeling survival data: extending the Cox model
- A new approach to causal inference in mortality studies with a sustained exposure period—application to control of the healthy worker survivor effect
- Performance guarantees for individualized treatment rules
- Penalized Q-learning for dynamic treatment regimens
- Optimal Dynamic Treatment Regimes
- Time‐Dependent ROC Curves for Censored Survival Data and a Diagnostic Marker
- Optimal Structural Nested Models for Optimal Sequential Decisions
- Demystifying Optimal Dynamic Treatment Regimes
- A Bayesian Machine Learning Approach for Optimizing Dynamic Treatment Regimes
- New Statistical Learning Methods for Estimating Optimal Dynamic Treatment Regimes
- Statistical methods for dynamic treatment regimes. Reinforcement learning, causal inference, and personalized medicine
- Q-learning with censored data
- Estimating Optimal Dynamic Treatment Regimes With Survival Outcomes
- Adaptive Treatment Strategies in Practice
- Predictive Bayesian inference and dynamic treatment regimes
- A Bayesian view of doubly robust causal inference: Table 1.
- Entropy Learning for Dynamic Treatment Regimes
- Dynamic Treatment Regimes
This page was built for publication: Dynamic treatment regimes using Bayesian additive regression trees for censored outcomes
Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q6205050)